The rapid development of vaccines against SARS-CoV-2 has become a global priority in order to halt the pandemic. At Eyam, award-winning and world-renowned immunologist, Dr. Wilfred Jefferies, is leading a team of researchers making rapid progress towards a safe, efficacious, and low dose vaccine.